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Sepsis is the subject of intense interest for clinicians, pol-
icy makers, patients, and researchers. Stakeholders around
the world are striving to improve sepsis awareness and
quality of care. The Surviving Sepsis Campaign, World
Sepsis Day, and mandatory reporting rules are but a few
examples of ongoing initiatives. All sepsis stakeholders
need accurate data on sepsis incidence, characteristics,
outcomes, and whether these are changing over time.
Without these it is almost impossible to plan appropriately
or to know whether our efforts to prevent sepsis and
improve care are bearing fruit.
The most common source for sepsis surveillance is
hospital discharge codes. Their advantages include wide-
spread availability and low cost. At first blush they also
appear relatively straightforward to analyze. On closer
inspection, however, they are fraught with subtleties and
uncertainties.
There are two prevailing strategies to identify sepsis
using diagnosis codes: 1) identify patients with explicit
codes for severe sepsis and septic shock, or 2) seek
patients with concurrent discharge codes for infection
and organ dysfunction, the so-called “implicit” method.
The second strategy has obvious limitations. Investiga-
tors have proposed at least 5 different sets of infection
and diagnosis codes to identify sepsis. Not surprisingly,
different methods suggest very different sepsis rates [1].
Moreover, simultaneous infection and organ dysfunction
codes at discharge do not reliably imply that organ
dysfunction was due to infection.
Explicit sepsis codes also have their limitations. They
were only added to the International Classification of
Disease (ICD9-CM) lexicon in 2002. Despite the passage
of almost 15 years since their release, clinicians and
coders are still becoming familiar with them and only
gradually introducing them into practice.
A recent study in Critical Care by Bouza et al. eluci-
dated the uptake rate of explicit diagnosis codes using data
from the Spanish national hospital discharge database for
the years 2006-2011 [2]. They queried the database for
sepsis using the explicit and one implicit strategy in a mu-
tually exclusive fashion. The fraction of total cases
assigned explicit codes rose from 51 % in 2006 to 64 % in
2011. Patients assigned explicit codes were sicker than pa-
tients with implicit codes alone: almost twice as many had
mechanical ventilation codes and ten times as many had
cardiovascular dysfunction codes. The in-hospital mortal-
ity rate for patients with explicit codes was almost double
that of patients with implicit codes alone (55 % vs 29 %).
This study has important implications for stakeholders
trying to understand sepsis epidemiology through code-
based analyses. It is clear that one cannot consider cases
identified using explicit codes interchangeably with those
identified through implicit codes. It is also clear that
tracking sepsis using explicit codes alone provides an
incomplete and changing picture of the septic popula-
tion. One might wonder, however, whether it’s feasible to
track sepsis adequately using the combined population
of patients with either explicit or implicit codes?
To answer this question we need to understand more
about the reliability of explicit and implicit codes. Do all
* Correspondence: mklompas@partners.org
1Department of Population Medicine, Harvard Medical School and Harvard
Pilgrim Health Care Institute, 401 Park Street, Suite 401, Boston, MA 02215,
USA
2Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Klompas and Rhee Critical Care  (2016) 20:396 
DOI 10.1186/s13054-016-1559-z
patients with these codes have clinically-confirmed
sepsis? Do these codes collectively capture all patients
with sepsis or do some cases receive neither explicit nor
implicit codes? Prior work suggests that the positive
predictive value is high for explicit sepsis codes but only
moderate for implicit codes [3]. Implicit codes identify
more patients with sepsis than explicit codes but most
critically, both strategies miss large numbers of patients
[3, 4]. Moreover, both explicit and implicit codes are be-
ing used more frequently over time and are thus captur-
ing an increasing fraction of the septic population [4–8].
Bouza et al. note that increases in coding rates in
Spain are probably not being driven by financial incen-
tives because Spain has a universal health care system
[2]. This still allows for the possibility, however, that cli-
nicians and hospitals are coding more patients over time
in response to the many campaigns to improve sepsis
awareness and recognition and as a part of hospitals’
due diligence to improve the fidelity of coding [9].
The rise in coding rates creates a major dilemma when
trying to track sepsis rates and outcomes over time. Are
higher rates due to more disease, more recognition, more
complete coding, or some combination of these? Are
lower mortality rates due to better care, better capture of
more subtle cases, or both?
More deeply, neither the explicit nor the implicit strat-
egies overcome the ongoing challenge of sepsis classifica-
tion. The new Sepsis-3 consensus definitions provide a
useful conceptual definition for sepsis (“life-threatening
organ dysfunction caused by a dysregulated host response
to infection”) but still leave clinicians with the difficult tasks
of deciding whether a given patient is infected and whether
organ dysfunction is attributable to infection [10, 11].
Sometimes the answers to these questions are obvious (for
example, a previously healthy patient presenting with fever,
headache, and hypotension who is found to have meningo-
coccal meningitis) but more often these questions are subtle
(for example, an elderly patient with a history of congestive
heart failure and dementia presenting with low grade fever,
confusion, shortness of breath, and a rise in serum creatin-
ine). Thoughtful clinicians often disagree about these more
subtle cases [12]. And retrospective reviews suggest that up
to 40 % of patients admitted to intensive care for sepsis
treatment may not be infected after all [13].
In sum, continuing efforts to improve sepsis recognition,
ongoing changes in the ways clinicians and hospitals as-
sign codes for sepsis and organ dysfunction, and persistent
uncertainties about sepsis diagnosis make sepsis surveil-
lance using diagnosis codes incredibly challenging. Trying
to track sepsis using diagnosis codes is like trying to meas-
ure a moving and uncertain target with a moving and un-
certain measuring stick. We desperately need better tools
for sepsis diagnosis and surveillance. One possibility is to
measure sepsis using electronic clinical data rather than
diagnosis codes. One can impute suspected infection from
microbiology and antibiotic orders, and organ dysfunction
from laboratory tests, procedures (such as mechanical
ventilation), and medications (such as vasopressors) [5, 6].
This will not solve the problems of diagnostic uncertainty
and changing thresholds to diagnose and treat sepsis, but
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